Blog
Get the latest news about liver diseases and more
Get the latest news about liver diseases and more
HU6 is a novel oral drug that reduces liver fat and body weight through controlled metabolic acceleration, showing promising results in clinical trials compared to placebo.
A large study shows that daily alcohol consumption, even in small amounts, worsens liver fibrosis in patients with metabolic liver disease.
A large study reveals that vitamin E can reduce liver fibrosis and improve liver health in patients, reinforcing its therapeutic value alongside diet and exercise.
A misdiagnosed case between primary biliary cholangitis and mild adult idiopathic ductopenia shows why obtaining a second medical opinion is essential in biliary duct disorders.
Frequent snoring is linked to a higher risk of fatty liver disease, independent of obesity or diabetes, underscoring the role of proper sleep in liver health.
Coffee consumption, due to caffeine, has psychoactive properties and health benefits, improving cognitive function and reducing disease risk, however, excessive intake can be harmful.
Infliximab shows positive results in autoimmune hepatitis resistant to conventional therapies, improving liver function in most patients and representing a potential future treatment option.
Women with early menarche show a higher risk of fatty liver disease. Later onset lowers this risk, highlighting the importance of monitoring weight and liver health.
3 de May de 2023
5 de January de 2025
13 de January de 2019
It is the second cause of liver transplantation in the USA and in the next 10 years is expected to be the first cause. It is a serious illness if it is not treated properly.
It is a viral infection of the liver that causes inflammation of the liver and the death of hepatocytes.
Up to 30% of patients with cryptogenic hepatitis can be caused by the seronegative hidden infection by hepatitis C virus (HIC).